Two studies from Fred Hutchinson show how bacteria could help tumors progress and resist treatment

Fred Hutch names eight recipients of 2023 Dr. Eddie Méndez Scholar Award

Juliana Hofstatter AzambujaCarlos Mendez-DorantesMaritza Puray-ChavezTigist TamirChristine VazquezJohanna Melo-CardenasGina Gallego LopezKari PriceFred Hutchinson Cancer Center has announced the recipients of the 2023 Dr. Eddie Méndez Scholar Award, which recognizes early-career underrepresented minority scientists and scientists with disabilities.

October 20, 2023

Vol.49 No.39

In Brief

Lawrence Fong named scientific director of Immunotherapy Integrated Research Center at Fred Hutch

Lawrence Fong, a genitourinary oncologist and expert in immunotherapy for solid tumors, was named scientific director of the Immunotherapy Integrated Research Center at Fred Hutchinson Cancer Center. He will begin the role July 1, 2024.

October 13, 2023

Vol.49 No.38

In the Archives

In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch

At 75, Chris Lundy is one of the longest living recipients of a bone marrow transplant.

September 15, 2023

Vol.49 No.34

By Deborah Doroshow and Alexandria Carolan

In Brief

Fred Hutchinson granted $38.7M to serve as national coordinating center for Asian American, Native Hawaiian & Pacific Islander health studies

Fred Hutchinson Cancer Center will be the national coordinating center for a new epidemiological cohort study among Asian Americans, Native Hawaiians and Pacific Islanders.

September 15, 2023

Vol.49 No.34

Clinical Roundup

Researchers identify biological signature that may identify refractory ovarian cancer patients

Using a novel proteogenomic strategy and a variety of machine learning tools, investigators from the Icahn School of Medicine at Mount Sinai, Fred Hutchinson Cancer Center, and University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer Institute have identified a 64-protein signature that may predict a subset of ovarian cancer patients who are unlikely to respond to chemotherapy.

August 11, 2023

Vol.49 No.32

In Brief

Sara Hurvitz named SVP of the Clinical Research Division at Fred Hutch, head of the Division of Hematology and Oncology at UW

Sara Hurvitz was named senior vice president of the Clinical Research Division at Fred Hutchinson Cancer Center and head of the newly united Division of Hematology and Oncology at the University of Washington Department of Medicine.

June 16, 2023

Vol.49 No.24

Two studies from Fred Hutchinson show how bacteria could help tumors progress and resist treatment

YOU MAY BE INTERESTED IN

Fred Hutch names eight recipients of 2023 Dr. Eddie Méndez Scholar Award

Lawrence Fong named scientific director of Immunotherapy Integrated Research Center at Fred Hutch

In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch

Fred Hutchinson granted $38.7M to serve as national coordinating center for Asian American, Native Hawaiian & Pacific Islander health studies

Researchers identify biological signature that may identify refractory ovarian cancer patients

Sara Hurvitz named SVP of the Clinical Research Division at Fred Hutch, head of the Division of Hematology and Oncology at UW

Renew today!

Subscriber content

Login